USPTO serial 79351651
EVLABIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 10, 2024
- Examiner
- THOMAS, JULIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EVLABIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pamela N. Hirschman
Pamela N. Hirschman Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for human use, namely, preparations for the prevention and treatment of cancer and kidney diseases or disorders, preparations for the prevention and treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, preparations for the prevention and treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, cognitive disorders, diabetes; biologic preparations for medical and therapeutic purposes, namely, preparations for the prevention and treatment of cancer and kidney diseases or disorders, preparations for the prevention and treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, preparations for the prevention and treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, cognitive disorders, diabetes | ACTIVE | — |
| 009 | Data processing equipment, computer hardware; downloadable and recorded computer software for providing, analyzing and generating reports in the field of healthcare, pharmaceutical and biomedical research; downloadable and recorded computer software for data processing in the field of healthcare, pharmaceutical and biomedical research; electronic data processing apparatus, downloadable and recorded software, computer programs and hardware for the scientific analysis and electronic storage of artificial intelligence data in the field of healthcare, pharmaceutical and biomedical research; all of the aforementioned goods in the field of healthcare, pharmaceutical and biomedical research; downloadable and recorded software for scientific analysis of clinical trial data in the fields of public health, healthcare, pharmaceutical and biomedical research and downloadable and recorded software for scientific analysis of data from clinical trials and data derived from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; downloadable computer software featuring computer databases of pharmaceuticals and medical information; downloadable computer software for management of medical practices and conducting medical research; downloadable computer software for measuring, monitoring, processing and tracking health and medical information; downloadable computer search engine software for obtaining and providing updated scientific, medicinal, pharmaceutical and clinical information; computer hardware and downloadable and recorded software for use with medicinal patient monitoring equipment and for receiving, processing, transmitting and displaying data in the field of healthcare; downloadable and recorded artificial intelligence software for tracking data for use in medical and scientific healthcare research | ACTIVE | — |
| 035 | Business data analysis and statistical analysis for business purposes relating to healthcare data, biomedical and pharmaceutical research and clinical trial data and data from post-authorization research for marketing of medicines and commercial post-launching of medicines; business analysis and professional business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; compilation of business data, analysis of business data and business management analysis in the field of pharmaceutical and biomedical research and development, clinical trials, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare; compilation of business data, analysis of business data and business management analysis for medical, public health and healthcare purposes; business research, business market research and statistical analysis of business data in the fields of public health, health care, biomedicine and pharmaceuticals, clinical trials and post-authorization research for the marketing of medicines and commercial post-launching of medicines; providing marketing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmaco-epidemiological research, public health and healthcare; business risk management and business risk assessment services in the fields of pharmaceuticals and biomedicine; business services provided to the healthcare industry, namely, the collection, business reporting, and analysis of healthcare data for business purposes | ACTIVE | — |
| 036 | Financial analysis of investments in pharmaceutical and biomedical research and development and clinical trials and post-authorization research; providing financial services with respect to securities and other financial instruments and products, namely, trading of and investments in securities and financial instruments and products for others; financial evaluation, tracking, analysis, forecasting, consultancy and research services relating to securities and other financial instruments; financial research related to financial instruments; clearing and reconciling financial transactions via blockchain technology; electronic funds transfer provided via blockchain technology | ACTIVE | — |
| 042 | Product research in the field of medical, pharmaceutical and biologic therapeutic products; medical research, pharmaceutical research and pharmaceutical drug development services; providing scientific research information in the field of medical, pharmaceuticals, biomedicine, clinical trials and post-authorization research and commercial post-launching of medicines; providing temporary use of online non-downloadable computer software containing databases of pharmaceutical products, medical information, clinical trial data and data derived from post-authorization research for the marketing of medicines and commercial post-launching of medicines; providing temporary use of online non-downloadable computer software for management of medical practices and conducting medical research; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medicinal information and for controlling and managing data and information related to healthcare services and patient medicinal information; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; providing temporary use of non-downloadable software for financial analytics via blockchain technology; providing temporary use of non-downloadable artificial intelligence computer programs on data networks for tracking data for use in medical and scientific research; software as a service (SaaS) featuring software platforms for database management in healthcare | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dr. Robert Kirmeier
- Other trademarks owned by Dr. Robert Kirmeier
- Other trademarks owned by EvlaBio AG
- Other trademarks owned by EvlaBio AG
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Similar marks named EVLABIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 10, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 17, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 10, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 10, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 1, 2024 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 14, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 6, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jun 18, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 11, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 11, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 29, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 13, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 26, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 6, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 6, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 4, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 4, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 4, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 30, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 30, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 30, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 12, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 6, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |